20-HETE and the kidney: Resolution of old problems and new beginnings

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 277, Issue 3 46-3, 1999, Pages

  McGiff, John C ^a   Quilley, John ^b  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

20 Hydroxyeicosatetraenoic acid; Cyclooxygenase; Cytochrome P 450 monooxygenases; Endothelin; Nitric oxide; Potassium channels; Preglomerular microvessels; Renal autoregulation; Thick ascending limb; Tubuloglomerular feedback; Tumor necrosis factor

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ANGIOTENSIN; CYTOCHROME P450; CYTOKINE; ENDOTHELIN 1; HYDROXYICOSATETRAENOIC ACID; ICOSANOID; NITRIC OXIDE; POTASSIUM CHANNEL; PROSTACYCLIN; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE;

AUTOREGULATION; BLOOD PRESSURE REGULATION; ELECTROLYTE EXCRETION; FEEDBACK SYSTEM; ION TRANSPORT; KIDNEY CIRCULATION; KIDNEY FUNCTION; KIDNEY TUBULE ABSORPTION; PRIORITY JOURNAL; REVIEW; SECOND MESSENGER;

EID: 0032871226     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1999.277.3.r607     Document Type: Review

References (125)

1. Abraham, N. G., J. H.-C. Lin, M. L. Schwartzman, R. D. Levere, and S. Shibahara. The physiological significance of heme oxygenase. Int. J. Biochem. 20: 543-558, 1988.
2. Alonso-Galicia, M., H. A. Drummond, K. K. Reddy, J. R. Falck, and R. J. Roman. Inhibition of 20-HETE production contributes to the vascular responses to nitric oxide. Hypertension 29: 320-325, 1997.
3. Arima, S., Y. Endo, H. Yaoita, K. Omata, S. Ogawa, K. Tsunoda, M. Abe, K. Takeuchi, K. Abe, and S. Ito. Possible role of P-450 metabolite of arachidonic acid in vasodilator mechanism of angiotensin II type 2 receptor in the isolated microperfused rabbit afferent arteriole. J. Clin. Invest. 100: 2816-2823, 1997.
4. Arima, S., K. Omata, S. Ito, K. Tsunoda, and K. Abe. 20-HETE requires increased vascular tone to constrict rabbit afferent arterioles. Hypertension 27: 781-785, 1996.
5. Askari, B., C. P. Bell-Quilley, D. Fulton, J. Quilley, and John C. McGiff. Analysis of eicosanoid mediation of the renal functional effects of hyperchloremia. J. Pharmacol. Exp. Ther. 282: 101-107, 1997.
6. Bayliss, W. M. On the local reactions of the arterial wall to changes of internal pressure. J. Physiol. (Lond.) 28: 220-231, 1901.
7. Bell, P. D., and L. G. Navar. Cytoplasmic calcium in the mediation of macula densa tubulo-glomerular feedback responses. Science 215: 670-673, 1982.
8. Bullivant, E. M. A., C. S. Wilcox, and W. J. Welch. Intrarenal vasoconstriction during hypochloremia: Role of thromboxane. Am. J. Physiol. 256 (Renal Fluid Electrolyte Physiol. 25): F152-F157, 1989.
9. Campbell, W. B., D. Gebremedhin, P. F. Pratt, and D. R. Harder. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ. Res. 78: 415-423, 1996.
10. Capdevila, J., N. Chacos, J. Werringloer, R. A. Prough, and R. W. Estabrook. Liver microsomal cytochrome P-450 and the oxidative metabolism of arachidonic acid. Proc. Natl. Acad. Sci. USA 78: 5362-5366, 1981.
11. Capdevilla, J. H., S. Wei, J. Yan, A. Karara, H. R. Jacobson, J. R. Falck, F. P. Guengerich, and R. N. DuBois. Cytochrome P-450 arachidonic acid epoxygenase. Regulatory control of the renal epoxygenase by dietary salt loading. J. Biol. Chem. 267: 21720-21726, 1992.
12. Carroll, M. A., M. Balazy, D.-D. Huang, S. Rybalova, J. R. Falck, and J. C. McGiff. Cytochrome P450-derived renal HETEs: Storage and release. Kidney Int. 51: 1696-1702, 1997.
13. Carroll, M. A., M. Balazy, P. Margiotta, J. R. Falck, and J. C. McGiff. Renal vasodilator activity of 5, 6-epoxyeicosatrienoic acid depends upon conversion by cyclooxygenase and release of prostaglandins. J. Biol. Chem. 268: 12260-12266, 1993.
14. Carroll, M. A., M. Balazy, P. Margiotta, D.-D Huang, J. R. Falck, and J. C. McGiff. Cytochrome P-450-dependent HETEs: profile of biological activity and stimulation by vasoactive peptides. Am. J. Physiol. 271 (Regulatory Integrative Comp. Physiol. 40): R863-R869, 1996.
15. 2 receptors (Abstract). Prostaglandins Leukot. Essent. Fatty Acids 57: 185, 1997.
16. Carroll, M. A., M. P. Garcia, J. R. Falck, and J. C. McGiff. Cyclooxygenase dependency of the renovascular actions of cytochrome P-450-derived arachidonate metabolites. J. Pharmacol. Exp. Ther. 260: 104-109, 1992.
17. Carroll, M. A., A., Sala, C. E. Dunn, J. C. McGiff, and R. C. Murphy. Structural identification of cytochrome P450-dependent arachidonate metabolites formed by rabbit medullary thick ascending limb cells. J. Biol. Chem. 266: 12306-12312, 1991.
18. Coceani, F. Control of the ductus arteriosus: a new function for cytochrome P450, endothelin and nitric oxide. Biochem. Pharmacol. 48: 1315-1318, 1994.
19. Coceani, F., L. Kelsey, E. Seidlitz, G. S. Marks, B. E. McLaughlin, H. J. Vreman, D. K. Stevenson, M. Rabinovitch, and C. Ackerley. Carbon monoxide formation in the ductus arteriosus in the lamb: implications for the regulation of muscle tone. Br. J. Pharmacol. 120: 599-608, 1997.
20. Cogan, M. Angiotensin II: a powerful controller of sodium transport in the early proximal tubule. Hypertension 15: 451-458, 1990.
21. Dillie, J. R., and W. J.Arendshorst. Enhanced tubuloglomerular feedback activity in rats developing spontaneous hypertension. Am. J. Physiol. 247 (Renal Fluid Electrolyte Physiol. 16): F672-F679, 1984.
22. Ca channels. Am. J. Physiol. 275 (Lung Cell. Mol. Physiol. 19): L423-L431, 1998.
23. Ellis, E. F., R. J. Police, L. Yancey, J. S. McKinney, and S. C. Amruthesh. Dilation of cerebral arterioles by cytochrome P-450 metabolites of arachidonic acid. Am. J. Physiol. 259 (Heart Circ. Physiol. 28): H1171-H1177, 1990.
24. Endou, H. Cytochrome P-450 monooxygenase system in the rabbit kidney: its intranephron localization and its induction. Jpn. J. Pharmacol. 33: 423-433, 1983.
25. Escalante, B., D. Erlij, J. R. Falck, and J. C. McGiff. Effect of cytochrome P450 arachidonate metabolites on ion transport in rabbit kidney loop of Henle. Science 251: 799-802, 1991.
26. Escalante, B., D. Erlij, J. R. Falck, and J. C. McGiff. Cytochrome P-450 arachidonate metabolites affect ion fluxes in rabbit medullary thick ascending limb. Am. J. Physiol. 266 (Cell Physiol. 35): C1775-C1782, 1994.
27. Escalante, B. A., N. R. Ferreri, C. E. Dunn, and J. C. McGiff. Cytokines affect ion transport in primary cultured thick ascending limb of Henle's loop cells. Am. J. Physiol. 266 (Cell Physiol. 35): C1568-C1576, 1994.
28. Escalante, B., W. C. Sessa, J. R. Falck, P. Yadagiri., and M. Laniado Schwartzman. Vasoactivity of 20-hydroxyeicosatetraenoic acid is dependent on metabolism by cyclooxygenase. J. Pharmacol. Exp. Ther. 248: 229-232, 1989.
29. Falck, J. R., S. Lumin, I. Blair, E. Dishman, M. V. Martin, D. J. Waxman, F. P. Guengerich, and J. H. Capdevila. Cytochrome P-450-dependent oxidation of arachidonic acid to 16-, 17- and 18-hydroxyeicosatetraenoic acid. J. Biol. Chem. 265: 10244-10249, 1990.
30. Ferreri, N. R., S.-J. An, and J. C. McGiff. Cyclooxygenase-2 expression and function in the medullary thick ascending limb. Am. J. Physiol. In Press
31. Ferreri, N. R., B. A. Escalante, Y. Zhao, S.-J. An, and J. C. McGiff. Angiotensin II induces TNF production by the thick ascending limb: functional implications. Am. J. Physiol. 274 (Renal Physiol. 43): F148-F155, 1998.
32. Ferreri, N. R., M. Schwartzman, N. G. Ibraham, P. N. Chander, and J. C. McGiff. Arachidonic acid metabolism in a cell suspension isolated from rabbit renal outer medulla. J. Pharmacol. Exp. Ther. 231: 441-448, 1984.
33. Ferreri, N. R., Y. Zhao, H. Takizawa, and J. C. McGiff. Tumor necrosis factor α-angiotensin interactions and regulation of blood pressure. J. Hypertens. 15: 1481-1484, 1997.
34. Franco, M., P. D. Bell, and L. G. Navar. Evaluation of prostaglandins as mediators of tubuloglomerular feedback. Am. J. Physiol. 254 (Renal Fluid Electrolyte Physiol. 23): F642-F649, 1988.
35. Fulton, D., M. Balazy, J. C. McGiff, and J. Quilley. Possible contribution of platelet cyclooxygenase to the renal vascular action of 5,6-epoxyeicosatrienoic acid. J. Pharmacol. Exp. Ther. 277: 1195-1199, 1996.
36. Fulton, D., J. C. McGiff, and J. Quilley. Pharmacological evaluation of an epoxide as the putative hyperpolarizing factor mediating the nitric oxide-independent vasodilator effect of bradykinin in the rat heart. J. Pharmacol. Exp. Ther. 287: 497-503, 1998.
37. Gaddum, J. H. Polypeptides Which Stimulate Plain Muscle. New York: Oxford University Press, 1955.
38. 2+ current. J. Physiol. (Lond.) 507: 771-781, 1998.
39. Gordon, J. A., and A. A. Spector. Effects of 12-HETE on renal tubular epithelial cells. Am. J. Physiol. 253 (Cell Physiol. 22): C277-C285, 1987.
40. Harder, D. R., D. Gebremedhin, J. Narayanan, C. Jefcoat, J. R. Falck, W. B. Campbell, and R. Roman. Formation and action of a P-450 4A metabolite of arachidonic acid in cat cerebral microvessels. Am. J. Physiol. 266 (Heart Circ. Physiol. 35): H2098-H2107, 1994.
41. Harder, D., J. Narayanan, D. Gebremedhin, and R. J. Roman. Transduction of physical force by the vascular wall. Trends Cardiovasc. Med. 5: 7-14, 1995.
42. Harris, P. J., J. Zuo, F. A. O. Mendelsohn, and S. L. Skinner. Hemodynamic and renal tubular effects of low doses of endothlin in anesthetized rats. J. Physiol. (Lond.) 433: 25-39, 1991.
43. Harris, R. C. The macula densa: recent developments. J. Hypertens. 14: 815-822, 1996.
44. Hayashi, K., M. Epstein, and R. Loutzenhiser. Enhanced myogenic responsiveness of renal interlobular arteries in spontaneously hypertensive rats. Hypertension 19: 153-160, 1992.
45. Helvig, C., E. Dishman, and J. H. Capdevila. Molecular, enzymatic, and regulatory characterization of rat kidney cytochrome P450 4A2 and 4A3. Biochemistry 37: 12546-12558, 1998.
46. Hession, C., J. M. Decker, A. P. Sherblom, S. Kumar, C. C. Yue, R. J. Mattaliano, R. Tizard, E. Kawashima, U. Schmeissner, S. Heletky, E. P. Chow, C. A. Burne, A. Shaw, and A. V. Muchmore. Uromodulin (Tamm-Horsfall glycoprotein): a renal ligand of lymphokines. Science 237: 1479-1484, 1987.
47. Hill, E., F. Fitzpatrick, and R. C. Murphy. Biological activity and metabolism of 20-hydroxyeicosatetraenoic acid in the human platelet. Br. J. Pharmacol. 106: 267-274, 1992.
48. Holla, V. K. R., A. Karara, K. Makita, E. Dishman, J. R. Falck, P. Zaphiropoulos, and J. H. Capdevila. The rat kidney cytochrome P450 2C23 arachidonic acid epoxygenase is upregulated during dietary salt loading. J. Clin. Invest. In press.
49. 2 and modulation by lipoxygenase and P-450 pathways. Am. J. Physiol. 273 (Renal Physiol. 42): F274-F282, 1997.
50. Imig, J. D., and L. G. Navar. Afferent arteriolar response to arachidonic acid: involvement of metabolic pathways. Am. J. Physiol. 271 (Renal Fluid Electrolyte Physiol. 40): F87-F93, 1996.
51. Imig, J. D., L. G. Navar, R. J. Roman, K. K. Reddy, and J. R. Falck. Actions of epoxygenase metabolites on the preglomerular vasculature. J. Am. Soc. Nephrol. 7: 2364-2370, 1996.
52. Imig, J. D., A.-P. Zou, D. E. Stec, D. R. Harder, J. R. Falck, and R. J. Roman. Formation and actions of 20-hydroxyeicosatetraenoic acid in rat renal arterioles. Am. J. Physiol. 270 (Regulatory Integrative Comp. Physiol. 39): R217-R227, 1996.
53. Ito, O., Alonso-Galicia, M., Hopp, K. A., and R. Roman. Localization of cytochrome P-450 4A isoforms along the rat nephron. Am. J. Physiol. 274 (Renal Physiol. 43): F395-F404, 1998.
54. Ito, S., S. Arima, Y. L. Ren, L. A. Juncos, and O. A. Carretero. Endothelium-derived relaxing factor/nitric oxide modulates angiotensin II action in the isolated microperfused rabbit afferent but not efferent arteriole. J. Clin. Invest. 91: 2012-2019, 1993.
55. Johnson, R. A., M. Lavesa, K. DeSeyn, M. J. Scholer, and A. Nasjletti. Heme oxygenase substrates acutely lower blood pressure in hypertensive rats. Am. J. Physiol. 271 (Heart Circ. Physiol. 40): H1132-H1138, 1996.
56. Karara, A., E. Dishman, J. R. Falck, and J. H. Capdevila. Endogenous epoxyeicosatrienoyl-phospholipids. J. Biol. Chem. 266: 7561-7569, 1991.
57. Kauser, K., J. E. Clark, B. S. Masters, P. R. Ortiz de Montellano, Y.-H. Ma, D. R. Harder, and R. J. Roman. Inhibitors of cytochrome P-450 attenuate the myogenic response to dog renal arcuate arteries. Circ. Res. 68: 1154-1163, 1991.
58. Khatsenko, O. G., S. S. Gross, A. B. Rifkind, and J. R. Vane. Nitric oxide is a mediator of the decrease in cytochrome P450-dependent metabolism caused by immunostimulants. Proc. Natl. Acad. Sci. USA 90: 11147-11151, 1993.
59. King, A. J., B. M. Brenner, and S. Anderson. Endothelin: a potent renal and systemic vasoconstrictor peptide. Am. J. Physiol. 256 (Renal Fluid Electrolyte Physiol. 25): F1051-F1058, 1989.
60. Kozma, F., R. A. Johnson, and A. Nasjletti. Role of carbon monoxide in heme-induced vasodilation. Eur. J. Pharmacol. 323: R1-R2, 1997.
61. Lange, A., D. Gebremedhin, J. Narayanan, and D. Harder. 20-hydroxyeicosatetraenoic acid-induced vasoconstriction and inhibition of potassium current in cerebral vascular smooth muscle is dependent on activation of protein kinase C. J. Biol. Chem. 272: 27345-27352, 1997.
62. Laniado-Schwartzman, M., J. R. Falck, P. Yadagiri, and B. Escalante. Metabolism of 20-hydroxyeicosatetraenoic acid by cyclooxygenase. Formation and identification of novel endothelium-dependent vasoconstrictor metabolite. J. Biol. Chem. 264: 11658-11662, 1989.
63. + channels in coronary smooth muscle through a guanine nucleotide binding protein. Circ. Res. 80: 877-884, 1997.
64. Lin, F., A. Rios, J. R. Falck, Y. Belosludisev, and M. L. Schwartzman. 20-Hydroxyeicosatetraenoic acid is formed in response to EGF and is a mitogen in rat proximal tubule. Am. J. Physiol. 269 (Renal Fluid Electrolyte Physiol. 38): F806-F816, 1995.
65. + channel in TAL of rat kidney. Am. J. Physiol. 274 (Renal Physiol. 43): F946-F950, 1998.
66. + channel in the thick ascending limb of the rat kidney. J. Gen. Physiol. 108: 537-547, 1996.
67. Ma, Y.-H., D. Gebremedhin, M. L. Schwartzman, J. R. Falck, J. E. Clark, B. S. Masters, D. R. Harder, and R. J. Roman. 20-Hydroxyeicosatetraenoic acid is an endogenous vasoconstrictor of canine renal arcuate arteries. Circ. Res. 72: 126-136, 1993.
68. Ma, Y.-H., M. L. Schwartzman, and R. J. Roman. Altered renal P-450 metabolism of arachidonic acid in Dahl salt-sensitive rats. Am. J. Physiol. 267 (Regulatory Integrative Comp. Physiol. 36): R579-R589, 1994.
69. Macica, C. M., B. A. Escalante, M. S. Conners, and N. R. Ferreri. TNF production by the medullary thick ascending limb of Henle's loop. Kidney Int. 46: 113-121, 1994.
70. Maines, M. D., and A. Kappas. Cobalt stimulation of heme degradation in the liver: dissociation of microsomal oxidation of heme from cytochrome P-450. J. Biol. Chem. 250: 4171-4177, 1975.
71. Makita, K., J. R. Falck, and J. H. Capdevila. Cytochrome P450, the arachidonic acid cascade, and hypertension: new vistas for an old enzyme system. FASEB J. 10: 1456-1463, 1996.
72. Makita, K., K. Takahashi, A. Karara, H. R. Jacobson, J. R. Falck, and J. H. Capdevilla. Experimental and/or genetically controlled alterations of the renal microsomal cytochrome P450 epoxygenase induced hypertension in rats fed a high salt diet. J. Clin. Invest. 94: 2414-2420, 1994.
73. McGiff, J. C. Cytochrome P-450 metabolism of arachidonic acid. Annu. Rev. Pharmacol. Toxicol. 31: 339-369, 1991.
74. McGiff, J. C., M. Steinberg, and J. Quilley. Missing links: cytochrome P450 arachidonic products. A new class of lipid mediators. Trends Cardiovasc. Med. 6: 1996.
75. Meschter, C. L., B. A. Mico, M. Mortillo, D. Feldman, W. A. Garland, J. A. Riley, and L. S. Kaufman. A 13-week toxicologic and pathologic evaluation of prolonged cytochromes P450 inhibition by 1-aminobenzotriazole in male rats. Fundam. Appl. Toxicol. 22: 369-381, 1994.
76. Navar, L. G., E. W. Inscho, J. D. Imig, and K. D. Mitchell. Heterogeneous activation mechanisms in the renal microvasculature. Kidney Int. 54: S17-S21, 1998.
77. Navar, L. G., E. W. Inscho, D. S. A. Majid, J. D. Imig, L. M. Harrison-Bernard, and K. D. Mitchell. Paracrine regulation of the renal microcirculation. Physiol. Rev. 76: 425-536, 1996
78. Nguyen, X., M.-H. Wang, K. M. Reddy, J. R. Falck, and M. L. Schwartzman. Kinetic profile of the rat CYP4A isoforms: arachidonic acid metabolism and isoform-specific inhibitors. Am. J. Physiol. In press.
79. Nowicki, S., S. L. Chen, O. Aizman, X. J. Cheng, D. Li, C. Nowicki, A. Nairn, P. Greengard, and A. Aperia. 20-Hydroxyeicosatetraenoic acid (20-HETE) activates protein kinase C. J. Clin. Invest. 99: 1224-1230, 1997.
80. Nüsslein-Volhard, C. Journey to the center of the egg. New York Times Magazine (October 12, 1997): p. 42-45.
81. Ordway, R. W., J. V. Walsh, and J. J. Singer. Arachidonic acid and other fatty acids directly activate potassium channels in smooth muscle cells. Science 244: 1176-1179, 1989.
82. Ortiz de Montellano, P. R., and M. A. Correia. Inhibition of cytochrome P450 enzymes. In: Cytochrome P450 (2nd ed.), edited by P. R. Ortiz de Montellano. New York: Plenum, 1995, p. 305-364.
83. Oyekan, A., M. Balazy, and J. C. McGiff. Renal oxygenases: differential contribution to vasoconstriction induced by ET-1 and angiotensin II. Am. J. Physiol. 273 (Regulatory Integrative Comp. Physiol. 42): R293-R300, 1997.
84. Oyekan, A. O., K. McAward, J. Conetta, L. Rosenfeld, and J. C. McGiff. Endothelin-1 and cytochrome P-450 arachidonate metabolites interact to promote tissue injury in DOCA/salt hypertension. Am. J. Physiol. 276 (Regulatory Integrative Comp. Physiol. 45): R766-R775, 1999.
85. Oyekan, A. O., and J. C. McGiff. Functional response of the rat kidney to inhibition of nitric oxide synthesis: role of cytochrome P450-derived arachidonate metabolites. Br. J. Pharmacol. 125: 1065-1073, 1998.
86. Oyekan, A. O., and J. C. McGiff. Cytochrome P-450-derived eicosanoids participate in the renal functional effects of endothelin-1 in the anesthetized rat. Am. J. Physiol. 274 (Regulatory Integrative Comp. Physiol. 43): R52-R61, 1998.
87. Oyekan, A. O., J. C. McGiff, and J. Quilley. Cytochrome P-450-dependent vasodilator responses to arachidonic acid in the isolated, perfused kidney of the rat. Circ. Res. 68: 958-965, 1991.
88. Perico, N., R. P. Cornejo, A. Benigni, B. Malanchini, J. R. Ladny, and G. Remuzzi. Endothelin induces diuresis and natriuresis in the rat by acting on proximal tubular cells through a mechanism mediated by lipoxygenase products. J. Am. Soc. Nephrol. 2: 57-69, 1991.
89. Pratt, P. F., J. R. Falck, M. R. Komandla, J. B. Kurian, and W. B. Campbell. 20-HETE relaxes bovine coronary arteries through the release of prostacyclin. Hypertension 31: 237-241, 1998.
90. Quilley, J., C. P. Bell-Quilley, and J. C. McGiff. Eicosanoids and hypertension. In: Hypertension: Pathophysiology, Diagnosis, and Management (2nd ed.), edited by J. H. Laragh and B. M. Brenner. New York: Raven, 1995, p. 963-982.
91. Quilley, J., D. Fulton, and J. C. McGiff. Hyperpolarizing factors. Biochem. Pharmacol. 54: 1059-1070, 1997.
92. +-ATPase through a cytochrome P-450 pathway. Am. J. Physiol. 266 (Renal Fluid Electrolyte Physiol. 35): F497-F505, 1994.
93. Sacerdoti, D., M. Balazy, P. Angeli, A. Gatta, and J. C. McGiff. Eicosanoid excretion in hepatic cirrhosis: predominance of 20-HETE. J. Clin. Invest. 100: 1264-1270, 1997.
94. Sacerdoti, D., B. A. Escalante, N. G. Abraham, J. C. McGiff, R. D. Levere, and M. L. Schwartzman. Treatment with tin prevents the development of hypertension in spontaneously hypertensive rats. Science 243: 388-390, 1989.
95. Sakairi, Y., H. R. Jacobson, T. D. Noland, J. H. Capdevila, J. R. Falck, and M. D. Breyer. 5,6-EET inhibits ion transport in collecting duct by stimulating endogenous prostaglandin synthesis. Am. J. Physiol. 268 (Renal Fluid Electrolyte Physiol. 37): F931-F939, 1995.
96. Kassab, S., M. T. Miller, J. Novak, J. Reckelhoff, B. Clower, and J. P. Granger. Endothelin-A receptor antagonism attenuates the hypertension and renal injury in Dahl salt-sensitive rats. Hypertension 31: 397-402, 1998.
97. Schmidt, H. H. NO, CO and HO endogenous soluble guanylyl cyclase-activating factors. FEBS Lett. 307: 102-107, 1992.
98. Schnackenberg, C. G., F. C. Wilkins, and J. P. Granger. Role of nitric oxide in modulating the vasoconstrictor actions of angiotensin II in preglomerular and postglomerular vessels in dogs. Hypertension 26: 1024-1029, 1995.
99. Schwartzman, M. L., N. G. Abraham, M. A. Carroll, R. D. Levere, and J. C. McGiff. Regulation of arachidonic acid metabolism by cytochrome P-450 in rabbit kidney. Biochem. J. 238: 283-290, 1986.
100. Schwartzman, M., M. A. Carroll, N. G. Ibraham, N. R. Ferreri, E. Songu-Mize, and J. C. McGiff. Renal arachidonic acid metabolism. The third pathway. Hypertension I136-I144, 1985.
101. +)ATPase. Nature 314: 620-622, 1985.
102. Schwartzman, M. L., and J. C. McGiff. Renal cytochrome P450. J. Lipid Mediat. Cell Signal. 12: 229-242, 1995.
103. Smith, W. L., F. C. Grenier, T. G. Bell, and G. P. Wilkin. Cellular distribution of enzymes involved in prostaglandin metabolism in the mammalian kidney. In: Prostaglandins in Cardiovascular and Renal Function. Jamaica, NY: Spectrum, 1980 p. 71-91.
104. + channel activity and vascular tone in renal arterioles. Circ. Res. 83: 1069-1079, 1998.
105. Sun, C.-W., J. R. Falck, D. R. Harder, and R. J. Roman. Role of tyrosine kinase and PKC in the vasoconstrictor response to 20-HETE in renal arterioles. Hypertension 33: 414-418, 1999.
106. Takahashi, K., J. Capdevila, A. Karara, J. R. Falck, H. R. Jacobson, and K. F. Badr. Cytochrome P-450 arachidonate metabolites in rat kidney: characterization and hemodynamic responses. Am. J. Physiol. 258 (Renal Fluid Electrolyte Physiol. 27): F781-F789, 1990.
107. Uddin, M. R., M. M. Muthalif, N. A. Karzoun, I. F. Benter, and K. U. Malik. Cytochrome P-450 metabolites mediate norepinephrine-induced mitogenic signaling. Hypertension 31: 242-247, 1998.
108. Van-Lanschot, J. J., K. Mealy, D. O. Jacobs, D. O. Evan, and D. W. Wilmore. Splenectomy attenuates the inappropriate diuresis associated with tumor necrosis factor administration. Surg. Gynecol. Obstet. 172: 293-297, 1991.
109. Wang, M.-H., E. Brand-Schieber, B. A. Zand, X. Nguyen, J. R. Falck, N. Balu, and M. L. Schwartzman. Cytochrome P450-derived arachidonic acid metabolism in the rat kidney: characterization of selective inhibitors. J. Pharmacol. Exp. Ther. 284: 966-973, 1998.
110. Wang, M.-H., D. E. Stec, M. Balazy, V. Mastyugin, C. S. Yang, R. J. Roman, and M. L. Schwartzman. Cloning, sequencing, and cDNA-directed expression of the rat renal CYP4A2: arachidonic acid ω-hydroxylation and 11,12-epoxidation by CYP4A2 protein. Arch. Biochem. Biophys. 336: 240-250, 1996.
111. + channel in the thick ascending limb of the rat kidney. J. Gen. Physiol. 106: 727-743, 1995.
112. + channels in rat TAL. Am. J. Physiol. 273 (Renal Physiol. 42): F421-F429, 1997.
113. + channels in the TAL. Am. J. Physiol. 271 (Cell Physiol. 40): C103-C111, 1996.
114. Weihprecht, H., J. N. Lorenz, J. P. Briggs, and J. Schnermann. Vasoconstrictor effect of angiotensin and vasopressin in isolated rabbit afferent arterioles. Am. J. Physiol. 261 (Renal Fluid Electrolyte Physiol. 30): F273-F282, 1991.
115. Wilcox, C., and W. J. Welch. TGF and nitric oxide: effects of salt intake and salt-sensitive hypertension. Kidney Int. 49 Suppl. 55: S9-S13, 1996.
116. Wilcox, C. S., W. J. Welch, F. Murad, S. S. Gross, G. Taylor, R. Levi, and H. H. Schmidt. Nitric oxide synthase in macula densa regulates glomerular capillary pressure. Proc. Natl. Acad. Sci. USA 89: 11993-11997, 1992.
117. Wink, D. A., Y. Osawa, J. F. Darbyshire, C. R. Jones, S. C. Eshenaur, and R. W. Nims. Inhibition of cytochromes P450 by nitric oxide and a nitric oxide-releasing agent. Arch. Biochem. Biophys. 300: 115-123, 1993.
118. Wong, P. Y.-K., P.-S. Lai, S.-Y. Shen, Y. Y. Belosludtsev, and J. R. Falck. Post-receptor signal transduction and regulation of 14(R),15(S)-epoxyeicosatrienoic acid (14,15-EET) binding in U-937 cells. J. Lipid Mediat. Cell Signal. 16: 155-169, 1997.
119. Wright, C. E., D. D. Rees, and S. Moncada. Protective and pathological role in nitric oxide in endotoxin shock. Cardiovasc. Res. 26: 48-57, 1992.
120. Yin, K., J. C. McGiff, and C. P. Bell-Quilley. Role of chloride in the variable response of the kidney to cyclooxygenase inhibition. Am. J. Physiol. 268 (Renal Fluid Electrolyte Physiol. 37): F561-F568, 1995.
121. Zhu, Y., E. Brand Schieber, J. C. McGiff, and M. Balazy. Identification of arachidonate P-450 metabolites in human platelet phospholipids. Hypertension 25: 854-859, 1995.
122. Zingarelli, B., F. Squandrito, D. Altavilla, G. Calapai, M. DiRosa, and A. P. Caputi. Role of tumor necrosis factor a in acute hypovolemic hemorrhagic schock in rats. Am. J. Physiol. 266 (Heart Circ. Physiol. 35): H1512-H1515, 1994.
123. + channel in renal arterioles. Am. J. Physiol. 270 (Regulatory Integrative Comp. Physiol. 39): R226-R237, 1996.
124. Zou, A.-P., J. D. Imig, M. Kaldunski, P. R. Ortiz de Montellano, Z. Sui, and R. J. Roman. Inhibition of renal vascular 20-HETE production impairs autoregulation of renal blood flow. Am. J. Physiol. 266 (Renal Fluid Electrolyte Physiol. 35): F275-F282, 1994.
125. Zou, A.-P., J. D. Imig, P. R. Ortiz de Montellano, Z. Sui, J. R. Falck, and R. J. Roman. Effect of P-450 ω hydroxylase metabolites of arachidonic acid on tubuloglomerular feedback. Am. J. Physiol. 266 (Renal Fluid Electrolyte Physiol. 35): F934-F941, 1994.